People · Operator

Patrick Kullmann

Named in public records as an officer, director or promoter · active 2011–2019 · Other Health Care

2
Companies
2
Filings
$1.8M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Streamline, Inc.Other Health CarePre-Seed$1.5M$14.7M2011
SubioMed, Inc.Other Health CarePre-Seed$283K$8.7M2019
Operator network

Patrick Kullmann at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Jim Phillips · 4 companies · 1 sharedJim PhillipsJames Albrecht · 2 companies · 1 sharedJames AlbrechtJohn Blank · 2 companies · 1 sharedJohn BlankPETER BLANKENSHIP · 2 companies · 1 sharedPETER BLANKENSHIPRick Schultz · 2 companies · 1 sharedRick SchultzRYAN DOUGLAS · 2 companies · 1 sharedRYAN DOUGLASDustin Thompson · 1 companies · 1 sharedDustin ThompsonJerry Nye · 1 companies · 1 sharedJerry NyeSamuel Blankenship · 1 companies · 1 sharedSamuel BlankenshipTom Vollmer · 1 companies · 1 sharedTom VollmerJohn Deedrick · 7 companies · 1 sharedJohn DeedrickBARRY BUTLER · 6 companies · 1 sharedBARRY BUTLERBrian Bowen · 1 companies · 1 sharedBrian BowenMarty Emerson · 1 companies · 1 sharedMarty EmersonStreamline, Inc. · $1.5M raisedStreamline, Inc.SubioMed, Inc. · $0.3M raisedSubioMed, Inc.Patrick KullmannPK
Patrick Kullmann Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Patrick Kullmann on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
John Deedrick17
BARRY BUTLER16
Jim Phillips14
James Albrecht12
PETER BLANKENSHIP12
RYAN DOUGLAS12
Rick Schultz12
John Blank12
Tom Vollmer11
Marty Emerson11
Brian Bowen11
Dustin Thompson11
Samuel Blankenship11
Jerry Nye11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.